Kevin A. Reynolds

Kevin A. Reynolds

Auto-generated profile, based on publicly available information

Kevin A. Reynolds

Department of Chemistry, Portland State University, Portland, Oregon 97201, United States

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2007 in Current Opinion in Microbiology
Verified
Journal Article
Open access
HWH Tonie Wright
H Tonie Wright
KRKevin A Reynolds
Kevin A Reynolds
The fatty acid biosynthesis pathway is an attractive but still largely unexploited target for the development of new antibacterial agents. The extended use of the antituberculosis drug isoniazid and the antiseptic triclosan, which are inhibitors of fatty acid biosynthesis, validates this pathway as a target for antibacterial development. Differences in subcellular organization of the bacterial and eukaryotic multienzyme fatty acid synthase systems offer the prospect of inhibitors with host versus target specificity. Platensimycin, platencin, and phomallenic acids, newly discovered natural product inhibitors of the condensation steps in fatty acid biosynthesis, represent new classes of compounds with antibiotic potential. An almost complete catalog of crystal structures for the enzymes of the type II fatty acid biosynthesis pathway can now be exploited in the rational design of new inhibitors, as well as the recently published crystal structures of type I FAS complexes.

28 July 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
AEAlessandra S. Eustáquio
Alessandra S. Eustáquio
RMRyan P. McGlinchey
Ryan P. McGlinchey
YLYuan Liu
Yuan Liu
CHChristopher Hazzard
Christopher Hazzard
LBLaura L. Beer
Laura L. Beer
BMBradley S. Moore
Bradley S. Moore
Polyketides are among the major classes of bioactive natural products used to treat microbial infections, cancer, and other diseases. Here we describe a pathway to chloroethylmalonyl-CoA as a polyketide synthase building block in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity. S -adenosyl- l -methionine (SAM) is converted to 5′-chloro-5′-deoxyadenosine (5′-ClDA) in a reaction catalyzed by a SAM-dependent chlorinase as previously reported. By using a combination of gene deletions, biochemical analyses, and chemical complementation experiments with putative intermediates, we now provide evidence that 5′-ClDA is converted to chloroethylmalonyl-CoA in a 7-step route via the penultimate intermediate 4-chlorocrotonyl-CoA. Because halogenation often increases the bioactivity of drugs, the availability of a halogenated polyketide building block may be useful in molecular engineering approaches toward polyketide scaffolds.

8 July 2011 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PKPapireddy Kancharla
Papireddy Kancharla
MSMartin Smilkstein
Martin Smilkstein
JKJane Xu Kelly
Jane Xu Kelly
SHShweta
Shweta
SSShaimaa M. Salem
Shaimaa M. Salem
KRKevin A. Reynolds
Kevin A. Reynolds

1 June 2001 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
DWDaniel J. Wilson
Daniel J. Wilson
YXYongquan Xue
Yongquan Xue
KRKevin A. Reynolds
Kevin A. Reynolds
DSDavid Sherman
David Sherman
The Streptomyces venezuelae pikD gene from the pikromycin biosynthetic cluster was analyzed, and its deduced product (PikD) was found to have amino acid sequence homology with a small family of bacterial regulatory proteins. Database comparisons revealed two hypothetical domains, including an N-terminal triphosphate-binding domain and a C-terminal helix-turn-helix DNA-binding motif. Analysis of PikD was initiated by deletion of the corresponding gene ( pikD ) from the chromosome of S. venezuelae , resulting in complete loss of antibiotic production. Complementation by a plasmid carrying pikD restored macrolide biosynthesis, demonstrating that PikD is a positive regulator. Mutations were made in the predicted nucleotide triphosphate-binding domain, confirming the active-site amino acid residues of the Walker A and B motifs. Feeding of macrolide intermediates was carried out to gauge the points of operon control by PikD. Although the pikD mutant strain was unable to convert macrolactones (10-deoxymethynolide and narbonolide) to glycosylated products, macrolide intermediates (YC-17 and narbomycin) were hydroxylated with high efficiency. To study further the control of biosynthesis, presumed promoter regions from pik cluster loci were linked to the xylE reporter and placed in S. venezuelae wild-type and pikD mutant strains. This analysis demonstrated that PikD-mediated transcriptional regulation occurs at promoters controlling expression of pikRII , pikAI , and desI but not those controlling pikRI or pikC .

16 January 2009 in ACS Chemical Biology
Verified
Journal Article
Closed access
TBTonia J. Buchholz
Tonia J. Buchholz
TGTodd W. Geders
Todd W. Geders
FBFrank E. Bartley
Frank E. Bartley
KRKevin A. Reynolds
Kevin A. Reynolds
JSJanet L. Smith
Janet L. Smith
DSDavid Sherman
David Sherman

23 June 1998 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DSD. L. Stassi
D. L. Stassi
SKS. J. Kakavas
S. J. Kakavas
KRK. A. Reynolds
K. A. Reynolds
GGG. Gunawardana
G. Gunawardana
SSS. Swanson
S. Swanson
LKL. Katz
L. Katz
A previously unknown chemical structure, 6-desmethyl-6-ethylerythromycin A (6-ethylErA), was produced through directed genetic manipulation of the erythromycin (Er)-producing organism Saccharopolyspora erythraea . In an attempt to replace the methyl side chain at the C-6 position of the Er polyketide backbone with an ethyl moiety, the methylmalonate-specific acyltransferase (AT) domain of the Er polyketide synthase was replaced with an ethylmalonate-specific AT domain from the polyketide synthase involved in the synthesis of the 16-member macrolide niddamycin. The genetically altered strain was found to produce ErA, however, and not the ethyl-substituted derivative. When the strain was provided with precursors of ethylmalonate, a small quantity of a macrolide with the mass of 6-ethylErA was produced in addition to ErA. Because substrate for the heterologous AT seemed to be limiting, crotonyl-CoA reductase, a primary metabolic enzyme involved in butyryl-CoA production in streptomycetes, was expressed in the strain. The primary macrolide produced by the reengineered strain was 6-ethylErA.